← Open Payments lookup

STEPHAN SIMONIAN: Open Payments

NPI 1104924208 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,899 in 103 payments from 12 companies in 2025. Trend: 2023 $3,022 · 2024 $2,234 · 2025 $2,899

Food & beverage: $2,899
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.13$502
Vanda Pharmaceuticals Inc.16$492
Alkermes, Inc.12$415
ABBVIE INC.15$383
Otsuka America Pharmaceutical, Inc.18$333
Janssen Pharmaceuticals, Inc10$325
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$149
Axsome Therapeutics, Inc.3$90
Almatica Pharma LLC3$74
Luye Pharma (USA) Ltd.3$57

Products named: COBENFY, HETLIOZ, VRAYLAR, INVEGA SUSTENNA, ARISTADA, REXULTI, CAPLYTA, LYBALVI.

Industry payments across CA — which companies pay providers there.